Bamco Inc. NY Reduces Stock Position in The Cooper Companies, Inc.

Hedge fund cuts holdings in medical device company by over 25%

Mar. 16, 2026 at 8:19am

Got story updates? Submit your updates here. ›

Bamco Inc. NY, a hedge fund, has reduced its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 25.4% during the 3rd quarter, according to a recent SEC filing. The fund now owns 663,738 shares of the medical device company's stock, down from 889,454 shares previously.

Why it matters

This reduction in Bamco's stake in Cooper Companies, a major player in the vision care and women's health products markets, could signal a shift in the hedge fund's investment strategy or outlook on the company's performance. Institutional investor activity is closely watched by analysts and investors as an indicator of market sentiment.

The details

According to the 13F filing, Bamco Inc. NY sold 225,716 shares of Cooper Companies during the 3rd quarter. The fund now owns approximately 0.33% of the company's outstanding stock, valued at $45.5 million as of the most recent filing.

  • Bamco Inc. NY reduced its Cooper Companies holdings during the 3rd quarter of 2026.

The players

Bamco Inc. NY

A hedge fund that has reduced its stake in The Cooper Companies, Inc.

The Cooper Companies, Inc.

A global medical device company that operates in the vision care and women's health products markets.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Bamco's position in Cooper Companies is a notable shift in the hedge fund's investment strategy, potentially signaling a change in its outlook on the medical device company's performance or the broader industry.